Combination of a haploidentical SCT with an unrelated cord blood unit: a single-arm prospective study

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Bone Marrow Transplantation

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bmt.2013.154PMID 24141650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

  2015cited by this paper
• Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial.

  2012cited by this paper
• Progress in haploidentical stem cell transplantation.

  2012cited by this paper
• Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant.

  2012cited by this paper
• Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

  2012cited by this paper
• Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia

  2011cited by this paper
• Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with leukemia: a systematic review and meta-analysis.

  2011cited by this paper
• Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants.

  2011cited by this paper
• Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival

  2011cited by this paper
• Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.

  2011cited by this paper
• Haploidentical hematopoietic transplantation: current status and future perspectives.

  2011cited by this paper
• BU- vs TBI-based conditioning for adult patients with ALL

  2011cited by this paper
• Relapsing hematologic malignancies after haploidentical hematopoietic stem cell transplantation.

  2011cited by this paper
• The great debate: haploidentical or cord blood transplant

  2011cited by this paper
• Strategies to enhance umbilical cord blood stem cell engraftment in adult patients

  2010cited by this paper
• Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.

  2010cited by this paper
• Expansion of human cord blood hematopoietic stem cells for transplantation.

  2010cited by this paper
• HLA-mismatched/haploidentical hematopoietic stem cell transplantation: a field in which Chinese doctors are making great contributions.

  2010cited by this paper
• The next frontier for stem cell transplantation: finding a donor for all.

  2010cited by this paper
• Access to hematopoietic stem cell transplantation

  2010cited by this paper
• Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution

  2010cited by this paper
• Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.

  2010cited by this paper
• Haematopoietic transplants combining a single unrelated cord blood unit and mobilized haematopoietic stem cells from an adult HLA-mismatched third party donor. Comparable results to transplants from HLA-identical related donors in adults with acute leukaemia and myelodysplastic syndromes.

  2010cited by this paper
• Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

  2010cited by this paper
• Haploidentical Transplantation for Leukemia

  2010cited by this paper
• Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.

  2010cited by this paper
• The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases.

  2010cited by this paper
• Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis

  2010cited by this paper
• Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.

  2009cited by this paper
• Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.

  2009cited by this paper
• Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor

  2009cited by this paper
• Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.

  2009cited by this paper
• Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children.

  2008cited by this paper
• HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

  2008cited by this paper
• Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial

  2008cited by this paper
• Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.

  2008cited by this paper
• Double unrelated reduced-intensity umbilical cord blood transplantation in adults.

  2007cited by this paper
• Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.

  2007cited by this paper
• Expanding the role of umbilical cord blood transplantation

  2007cited by this paper
• Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.

  2007cited by this paper
• Alternative donor transplantation in acute myeloid leukemia: which source and when?

  2007cited by this paper
• Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

  2006cited by this paper
• Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor.

  2006cited by this paper
• Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

  2005cited by this paper
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

  2005cited by this paper
• National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

  2005cited by this paper
• Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect

  2004cited by this paper
• In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.

  2004cited by this paper
• Unrelated umbilical cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor.

  2003cited by this paper
• Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms

  2001cited by this paper
• Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients

  2001cited by this paper
• Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in Italy.

  1997cited by this paper
• 1994 Consensus Conference on Acute GVHD Grading.

  1995cited by this paper

• Desensitization therapy using sirolimus and anti-CD20 monoclonal antibody based regimen in haploidentical transplant recipients positive for donor-specific anti-HLA antibodies.

  2026cites this paper
• A model developed by machine learning and principal component analysis for predicting bronchiolitis obliterans syndrome after allogeneic HSCT in a Chinese population with hematologic malignancies

  2025cites this paper
• Preformed anti-HLA DQA1/DQB1 DSA possibly responsible for graft failure in haploidentical stem cell transplantation

  2025cites this paper
• Haploidentical transplantation combined with mesenchymal stem cells co-infusion improves survival in severe aplastic anemia: a single-center retrospective study

  2025influential citation
• Combined unrelated donor allogeneic hematopoietic stem cell transplantation and unrelated cord blood transfusion for patients with hematological malignancies

  2025cites this paper
• 脐带血辅助单倍体外周血干细胞移植与无关供者外周血干细胞移植治疗恶性血液病的疗效比较

  2024cites this paper
• Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. – A review of techniques and analysis of outcomes

  2024cites this paper
• Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial

  2024influential citation
• Risk factors and survival analysis of human leukocyte antigen loss in relapsed acute myeloid leukaemia/myelodysplastic syndrome patients after allogeneic haematopoietic stem cell transplantation

  2024cites this paper
• The efficacy and safety of third-party umbilical blood/umbilical cord mesenchymal stem cell assisted related haploid hematopoietic stem cell transplantation in pediatric patients with acute leukemia: an observational study

  2024cites this paper
• Haplo-Cord transplantation with 8mg/kg anti-thymocyte globulin as graft-versus-host disease prophylaxis compared to haploidentical transplantation with 10mg/kg anti-thymocyte globulin in the treatment of acute leukemia.

  2023cites this paper
• The impact of donor‐specific anti‐HLA antibody levels on primary poor graft function and graft rejection in rituximab desensitized haploidentical stem cell transplantation

  2023cites this paper
• A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients

  2022cites this paper
• The clinical outcomes of mixed engraftment patients treated with haploidentical stem cells combined with umbilical cord blood transplantation

  2022cites this paper
• Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation

  2022cites this paper
• Association between haploidentical hematopoietic stem cell transplantation combined with an umbilical cord blood unit and graft-versus-host disease in pediatric patients with acquired severe aplastic anemia

  2022cites this paper
• Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation

  2022cites this paper
• Haplo-peripheral blood stem cell plus cord blood grafts for hematologic malignancies might lead to lower relapse compared with haplo-peripheral blood stem cell plus bone marrow grafts.

  2022cites this paper
• Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation Supported by Third-Party Cord Blood Versus Human Leukocyte Antigen-Matched Sibling Peripheral Blood Stem Cell Transplantation in Hematologic Malignancy Patients

  2022cites this paper
• Treatments of Ph-like acute lymphoblastic leukemia: a real-world retrospective analysis from a single large center in China

  2022cites this paper
• Improved outcomes using unmanipulated haploidentical hematopoietic stem cells combined with third‐party umbilical cord blood transplantation for non‐malignant diseases in children: The experience of a single center

  2021cites this paper
• The clinical outcomes of B-cell Acute Lymphoblastic Leukemia Patients Treated with Haploidentical Stem Cells Combined with Umbilical Cord Blood Transplantation.

  2021cites this paper
• Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes

  2021cites this paper
• Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody

  2020cites this paper
• Combining haplo-identical and cord blood stem cell grafts – might the whole be greater than the sum of its parts?

  2020cites this paper
• Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes

  2020cites this paper
• Impact of donor and recipient characteristics on graft-versus-host disease and survival in HLA-matched sibling hematopoietic stem cell transplantation.

  2020cites this paper
• Combination of haploidentical haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 cases

  2020cites this paper
• Double‐unit unrelated cord blood transplantation for thalassemia major: Comparison with HLA‐identical sibling bone marrow transplantation

  2020cites this paper
• Haploidentical stem cells combined with a small dose of umbilical cord blood transplantation exert similar survival outcome of HLA-matched stem cells transplantation in T-cell acute lymphoblastic leukemia

  2019cites this paper
• Clinical Features of Chronic Graft-Versus-Host Disease Following Haploidentical Transplantation Combined with Infusion of a Cord Blood

  2019cites this paper
• Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation

  2019cites this paper
• Comparison of outcomes of haploidentical donor hematopoietic stem cell transplantation supported by third-party cord blood with HLA-matched unrelated donor transplantation

  2019cites this paper
• Combination of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation With Unrelated Cord Blood Unit in Patients Aged 35 to 50 Years With Severe Aplastic Anemia: Preliminary Summary of a Single-Arm Trial.

  2019cites this paper
• 单倍型造血干细胞移植后闭塞性细支气管炎综合征的临床分析

  2019cites this paper
• Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children

  2019cites this paper
• Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study

  2018cites this paper
• Myeloablative conditioning regimens with combined of haploidentical and cord blood transplantation for myelodysplastic syndrome patients

  2018cites this paper
• Haploidentical Transplantation Using Unmanipulated G-CSF-Primed Blood and Marrow as Allografts: Clinical Data and Challenges

  2018cites this paper
• 单倍型造血干细胞联合第三方脐血干细胞移植治疗重型再生障碍性贫血127例临床观察

  2018cites this paper
• Salvaged allogeneic hematopoietic stem cell transplantation for pediatric chemotherapy refractory acute leukemia

  2017influential citation
• Haploidentical hematopoietic stem cell transplantation with myeloablative conditioning regimen could serve as an optional salvage therapy for younger patients with refractory or relapsed aggressive non-Hodgkin lymphoma

  2017cites this paper
• Advances in Stem Cell Therapy for Leukemia.

  2016cites this paper
• Predictive value of high EVI1 expression in AML patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation in first CR

  2016cites this paper
• 在家系完整的单倍体联合第三方脐血移植中研究供受者HLA单倍型和等位基因错配对移植预后的影响

  2016cites this paper
• Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience.

  2016cites this paper
• Combination of a Haploidentical Stem Cell Transplant With Umbilical Cord Blood for Cerebral X-Linked Adrenoleukodystrophy.

  2015cites this paper
• Clinical Use of Umbilical Cord Blood Cells

  2015cites this paper
• Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.

  2015cites this paper
• Improving The Efficacy And Availability Of Stem Cell Transplant Therapies For Hematopoietic Stem Cell Transplantation

  2014cites this paper
• Allogeneic transplantation as anticancer immunotherapy.

  2014cites this paper
• Current Strategies to Improve Engraftment in Cord Blood Transplantation

  2014cites this paper
• Haploidentical stem cell transplantation for the treatment of leukemia: current status

  2014cites this paper